ALX Oncology begins dosing in phase 2/3 trial of evorpacept in gastric cancer
March 02 2022 - 8:00AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
ALX Oncology (NASDAQ:ALXO)
Historical Stock Chart
From Mar 2024 to Apr 2024
ALX Oncology (NASDAQ:ALXO)
Historical Stock Chart
From Apr 2023 to Apr 2024